MedElevator Войти в исследования
← Поиск публикаций

DOI 10.23736/s0031-0808.20.03961-0

Медицинская библиотека · Panminerva medica · 2021

Primary benign back pain: supplementation with Pycnogenol®.

Cox David, Belcaro Gianni, Cesarone Maria R, Cotellese Roberto, Dugall Mark, Feragalli Beatrice, Hosoi Morio, Corsi Marcello, Luzzi Roberta

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Back pain (BP) is one of the most common problems seen by general practitioners. The aim of this pilot registry study was to evaluate the effects of Pycnogenol® (French Maritime Pine Bark extract) on pain, mobility and muscle spasm in patients with recurring episodes of back pain without any other clinical condition.

METHODS

The registry follow-up lasted 3 weeks. Subjects used either SM (standard management), including mild exercise and 3 days of resting or immobilization - or SM+Pycnogenol® 200 mg/day (4 cps/day).

RESULTS

Eighty-two subjects were included in the study, 23 took Pycnogenol® and 59 were in the SM group. No safety problems or tolerability problems were observed with Pycnogenol® or with the SM. The two groups, SM and SM+Pycnogenol®, were comparable at inclusion. A prevalent localization to the lower part of the back/spine was observed in all patients of both groups. The improvement in Karnofsky performance status Scale - expressing the global physical capacity of the individuals - during the 3 weeks of follow-up was significantly higher and faster in the Pycnogenol® group (P<0.05) compared to SM. Patients were able to restart physical training in 3 weeks with Pycnogenol® (in comparison with 4.5 weeks with SM only). The decrease in back pain score (VASL score) was faster and more pronounced with Pycnogenol® (P<0.05) compared to SM. Oxidative stress was significantly reduced in subjects using Pycnogenol® (P<0.05) while it remained elevated in the control group. The use of the rescue medication doses (ibuprofen) was significantly higher in the SM only (P<0.05) in comparison with SM+Pycnogenol®.

CONCLUSIONS

Pycnogenol® appears to be an effective and safe supplementary management in healthy subjects with idiopathic BP. Mobility, pain, general physical capacity and oxidative stress improved in only a week with further improvements up to 4 weeks in most patients; results appear to be better and faster with Pycnogenol® supplementation than with SM alone.

Для цитирования: Cox David, Belcaro Gianni, Cesarone Maria R, Cotellese Roberto, Dugall Mark, Feragalli Beatrice, Hosoi Morio, Corsi Marcello, Luzzi Roberta. Primary benign back pain: supplementation with Pycnogenol®.. Panminerva medica. 2021. DOI: 10.23736/s0031-0808.20.03961-0.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.